Paper35366192
Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals.
Schifano F and 8 others. Drugs, 2022. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals. Papers, record 35366192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35366192
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Central Nervous System Stimulants | Major topic |
| Methylphenidate | Major topic |
| Nootropic Agents | Major topic |
| Brain | |
| Cognition | |
| Humans | |
| Modafinil |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 35476318 | Correction to: Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals. | https://conductscience.org/library/papers/35476318 |
Source PubMed
References117
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24860437 | Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain. | Front Syst Neurosci | 2014 | https://conductscience.org/library/papers/24860437 | PubMed |
| 2 | 26381811 | Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review. | Eur Neuropsychopharmacol | 2015 | https://conductscience.org/library/papers/26381811 | PubMed |
| 3 | 34137904 | Acute drug effects differentially predict desire to take dextroamphetamine again for work and recreation. | Psychopharmacology (Berl) | 2021 | https://conductscience.org/library/papers/34137904 | PubMed |
| 4 | 22886028 | Cognitive enhancers (nootropics). Part 1: drugs interacting with receptors. | J Alzheimers Dis | 2012 | https://conductscience.org/library/papers/22886028 | PubMed |
| 5 | 15107192 | Neuropsychological test performance in healthy volunteers before and after donepezil administration. | J Psychopharmacol | 2004 | https://conductscience.org/library/papers/15107192 | PubMed |
| 6 | 30550256 | Hacking the Brain: Dimensions of Cognitive Enhancement. | ACS Chem Neurosci | 2019 | https://conductscience.org/library/papers/30550256 | PubMed |
| 7 | 21931653 | Donepezil impairs memory in healthy older subjects: behavioural, EEG and simultaneous EEG/fMRI biomarkers. | PLoS One | 2011 | https://conductscience.org/library/papers/21931653 | PubMed |
| 8 | 34616318 | Psychological Distress and Use of Psychotropic Drugs Among University Students-the SHoT Study, Norway. | Front Psychiatry | 2021 | https://conductscience.org/library/papers/34616318 | PubMed |
| 9 | 25831025 | Unifi nootropics from the lab to the web: a story of academic (and industrial) shortcomings. | J Enzyme Inhib Med Chem | 2016 | https://conductscience.org/library/papers/25831025 | PubMed |
| 10 | 22469221 | Donepezil. | Profiles Drug Subst Excip Relat Methodol | 2010 | https://conductscience.org/library/papers/22469221 | PubMed |
| 11 | 28464963 | Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trial. | Psychol Med | 2017 | https://conductscience.org/library/papers/28464963 | PubMed |
| 12 | 11031090 | Postinjury administration of L-deprenyl improves cognitive function and enhances neuroplasticity after traumatic brain injury. | Exp Neurol | 2000 | https://conductscience.org/library/papers/11031090 | PubMed |
| 13 | 32794136 | Is Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement? | CNS Drugs | 2020 | https://conductscience.org/library/papers/32794136 | PubMed |
| 14 | 22536538 | Neuroprotective effects of meloxicam and selegiline in scopolamine-induced cognitive impairment and oxidative stress. | Int J Alzheimers Dis | 2012 | https://conductscience.org/library/papers/22536538 | PubMed |
| 15 | 34209645 | Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History. | Int J Environ Res Public Health | 2021 | https://conductscience.org/library/papers/34209645 | PubMed |
| 16 | 22194080 | Overview of literature and information on "khat-related" mortality: a call for recognition of the issue and further research. | Ann Ist Super Sanita | 2011 | https://conductscience.org/library/papers/22194080 | PubMed |
| 17 | 20163115 | Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors. | J Med Chem | 2010 | https://conductscience.org/library/papers/20163115 | PubMed |
| 18 | 33216781 | Professionals' attitudes towards the use of cognitive enhancers in academic settings. | PLoS One | 2020 | https://conductscience.org/library/papers/33216781 | PubMed |
| 19 | 24259638 | A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). | Ann Pharmacother | 2014 | https://conductscience.org/library/papers/24259638 | PubMed |
| 20 | 30106194 | Modafinil and the risk of cardiovascular events: Findings from three US claims databases. | Pharmacoepidemiol Drug Saf | 2018 | https://conductscience.org/library/papers/30106194 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42518442 | Design and Synthesis of Novel Bioactive Squamolone Derivatives Targeting Carbonic Anhydrase and Acetylcholinesterase Enzymes. | ACS Omega | 2026 | https://conductscience.org/library/papers/42518442 | PubMed |
| 42515793 | Cognitive and Mood Effects of a Soluble Mango Leaf Extract (Zynamite® S): A Randomized, Double-Blind, Placebo-Controlled, Crossover Replication Trial. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42515793 | PubMed |
| 42461702 | The use of Image and Performance-Enhancing Drugs (IPED) in behavioural addictions. | J Behav Addict | 2026 | https://conductscience.org/library/papers/42461702 | PubMed |
| 42280440 | Herbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis. | Nutrients | 2026 | https://conductscience.org/library/papers/42280440 | PubMed |
| 41898131 | Developing Messages to Prevent Smokeless Tobacco and Nicotine Pouch Uptake Among Early Career Rural Firefighters in California: A Qualitative Study. | Behav Sci (Basel) | 2026 | https://conductscience.org/library/papers/41898131 | PubMed |
| 41464961 | Advances in GABA-Enriched Yogurt and Frozen Yogurt: Microbial Biosynthesis, Functional Properties, and Health Perspectives-A Comprehensive Review. | Foods | 2025 | https://conductscience.org/library/papers/41464961 | PubMed |
| 41169870 | Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024. | F1000Res | 2025 | https://conductscience.org/library/papers/41169870 | PubMed |
| 41143009 | The association between test anxiety, learning strategies, and open-label placebo effects on academic test performance: a secondary analysis of a randomized controlled trial. | Front Psychol | 2025 | https://conductscience.org/library/papers/41143009 | PubMed |
| 41007388 | Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and "Smart Drug" Use and Misuse. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/41007388 | PubMed |
| 40800434 | Higher general intelligence is associated with stable, efficient, and typical dynamic functional brain connectivity patterns. | Imaging Neurosci (Camb) | 2024 | https://conductscience.org/library/papers/40800434 | PubMed |
| 40787538 | Exploring Cognitive Enhancers: from neurotherapeutics to ethical and regulatory challenges: a mini review. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/40787538 | PubMed |
| 40650226 | Positive AMPA and Kainate Receptor Modulators and Their Therapeutic Potential in CNS Diseases: A Comprehensive Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40650226 | PubMed |
| 40626304 | Unveiling the role of erinacines in the neuroprotective effects of Hericium erinaceus: a systematic review in preclinical models. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40626304 | PubMed |
| 40421258 | Pharmacotherapy for Poststroke Cognitive Impairment and Poststroke Cognitive Impairment With Dementia: A Review. | Stroke Res Treat | 2025 | https://conductscience.org/library/papers/40421258 | PubMed |
| 40284006 | Acute Supplementation of Soluble Mango Leaf Extract (Zynamite® S) Improves Mental Performance and Mood: A Randomized, Double-Blind, Placebo-Controlled Crossover Study. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40284006 | PubMed |
| 40149748 | Effect of a Plant-Based Nootropic Supplement on Perceptual Decision-Making and Brain Network Interdependencies: A Randomised, Double-Blinded, and Placebo-Controlled Study. | Brain Sci | 2025 | https://conductscience.org/library/papers/40149748 | PubMed |
| 38808119 | Development of White Cabbage, Coffee, and Red Onion Extracts as Natural Phosphodiesterase-4B (PDE4B) Inhibitors for Cognitive Dysfunction: In Vitro and In Silico Studies. | Adv Pharmacol Pharm Sci | 2024 | https://conductscience.org/library/papers/38808119 | PubMed |
| 38467484 | Modafinil, an atypical CNS stimulant? | Adv Pharmacol | 2024 | https://conductscience.org/library/papers/38467484 | PubMed |
| 37367511 | Who Wants to Enhance Their Cognitive Abilities? Potential Predictors of the Acceptance of Cognitive Enhancement. | J Intell | 2023 | https://conductscience.org/library/papers/37367511 | PubMed |
| 36721145 | Methylphenidate use and misuse among medical residents in Israel: a cross-sectional study. | Hum Resour Health | 2023 | https://conductscience.org/library/papers/36721145 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35366192
GET https://conductscience.org/api/papers/v1/35366192/references?page=2